SETH SANDESH bought ATNM
September 2, 2026 · Form 4 insider transaction
SETH SANDESH bought 1,027,274 shares of Actinium Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,027,274
Price
$0.00
Total value
N/A
InsiderSETH SANDESH
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateSeptember 2, 2026
Filing dateSeptember 4, 2026
Shares owned after1,965,355
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a grant of RSUs. These RSUs vest fully on the third anniversary of the date of grant.